SCHEMBL13460760

SCHEMBL13460760

C=C(C)Nc1ccc(I)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IDO1 P14902 1/20 0.47
▸ SIGMAR1 Q99720 1/20 0.44
▸ CA12 O43570 3/20 0.40
▸ CA1 P00915 3/20 0.40
▸ CA2 P00918 3/20 0.40
▸ CA9 Q16790 3/20 0.40
▸ FPR2 P25090 3/20 0.40
▸ TRPV1 Q8NER1 2/20 0.39
▸ HTT P42858 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ EPHX2 P34913 2/20 0.38
▸ EPHX1 P07099 1/20 0.38
▸ RXFP1 Q9HBX9 1/20 0.37
▸ HDAC1 Q13547 1/20 0.37
▸ HDAC7 Q8WUI4 1/20 0.37
▸ HDAC8 Q9BY41 1/20 0.37
▸ HDAC6 Q9UBN7 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ MEN1 O00255 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19825999 0.87 SMN1; SMN2 (0.46) CA12CA1CA2CA9HTT
SCHEMBL8164496 0.79 RXFP1 (0.62) IDO1CA12CA1CA2CA9
SCHEMBL12209638 0.78 MAPT (0.60) CA12CA1CA2CA9HTT
SCHEMBL10057892 0.78 TDP1 (0.60) SIGMAR1HTTSMN1; SMN2TDP1MEN1
SCHEMBL12973183 0.76 MAPT (0.54) CA12CA1CA2CA9HTT
SCHEMBL13424786 0.76 MEN1 (0.52) IDO1HTTSMN1; SMN2MEN1ALDH1A1
SCHEMBL669782 0.76 SMN1; SMN2 (0.67) CA12CA1CA2CA9HTT
SCHEMBL22384713 0.76 NPC1 (0.43) CA12CA1CA2CA9HTT
SCHEMBL20725724 0.76 ALDH1A1 (0.52) HTTSMN1; SMN2EPHX1MEN1ALDH1A1
SCHEMBL28294619 0.76 TAS2R38 (0.60) IDO1SIGMAR1CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010024356-A1 NOVEL HYDROXAMIC ACID DERIVATIVE HAVING NAPHTHYRIDINE-N-OXIDE 大正製薬株式会社 (JP) 2010-03-04 — — WO disclosed
Send feedback